VT Might Smarter Than Right: A Global ETF Edge for 2026
Through March 21, 2026, VT is down less than 1% year-to-date while SPY slides about 3%, signaling a shift toward glob...
Using Spreadsheets For Investment Planning
Spreadsheets are powerful tools for investment planning. Discover how to utilize them to track and manage your investments efficiently.
20,347 articles
Israel Says ‘War Close’ as Nuclear Center Targeted
Israel confirms its first strike on the Dimona nuclear research site as tensions with Iran escalate, pushing markets ...
Markets Meltdown After Trump Threatens Major Iran Escalation
Global markets tumbled as President Trump signaled a major escalation with Iran, sending oil higher and volatility so...
These Chip Stocks Could Boom as Terafab Vision Takes Hold
Analysts see Elon Musk's Terafab strategy as a potential catalyst for chip-equipment makers and select chip stocks, b...
FuboTV Slides Reverse Stock Split Spooks Retail Investors
FuboTV's reverse stock split reduces outstanding Class A and Class B shares, triggering a debate among retail investo...
Stock Market Today, March: Nokia Signals 5G Momentum
Nokia climbs on 5G demand and North American telecom spend, while broader markets drift. A practical look at what thi...
Stock Market Crash: This Magnificent Seven Stock Is Bargain
When the market shakes, a top-tier stock can become a compelling bargain. This guide breaks down why one Magnificent ...
Notorious Short-Seller Unloaded SoFi, Stock Still Steady
A notorious short-seller unloaded sofi this week with sweeping accusations, but the stock shrugged off most of the blow.
This Stock’s Downgrade Shows War Costs Hit Markets
Geopolitical frictions with Iran are boosting energy and raw-material costs. A prominent downgrade underscores how th...
Designer Brands (DBI) 2025 Earnings: Investor Guide
What happened in Designer Brands (DBI) 2025 earnings, and what it means for investors in 2026. This guide breaks down...
XRP News: Institutions Plan Include 2026 Allocations
A new survey of 351 institutions finds 25% intend to add XRP in 2026, joining the 18% already holding the token. Pric...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status